ATGC-110

N/A

Report date: 2024/10/24 14:06:15

Base Information

Drug NameATGC-110
Drug Alias NameATGC-110
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsGlabellar lines
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtgc Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAtgc Co LtdHuadong Medicine Aesthetics Investment (HongKong) Ltd
Inactive CompaniesN/A
Active IndicationsGlabellar lines
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A